(Q35537909)

8 August 2017

1 reference

title

Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosis (English)

1 reference

8 August 2017

Lysophosphatidic acid acyltransferase-β: a novel target for induction of tumour cell apoptosis (English)

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

11 March 2024

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

11 March 2024

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

11 March 2024

author name string

Lynn Bonham

1

1 reference

8 August 2017

Thayer White

3

1 reference

8 August 2017

David Hollenback

4

1 reference

8 August 2017

Peter Klein

5

1 reference

8 August 2017

John Tulinsky

6

1 reference

8 August 2017

Michael Coon

7

1 reference

8 August 2017

Peter de Vries

8

1 reference

8 August 2017

David W. Leung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14498826

11 March 2024

Jack W. Singer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14498826

11 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14728222.7.5.643

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Expert Opinion on Therapeutic Targets

11 March 2024

published in

1 reference

8 August 2017

volume

7

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

643-661

1 reference

The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Arsenic trioxide, a therapeutic agent for APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

How acute promyelocytic leukaemia revived arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Characterization of a human lysophosphatidic acid acyltransferase that is encoded by a gene located in the class III region of the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Cloning of a coconut endosperm cDNA encoding a 1-acyl-sn-glycerol-3-phosphate acyltransferase that accepts medium-chain-length substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Analysis of the structure, substrate specificity, and mechanism of squash glycerol-3-phosphate (1)-acyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Eukaryotic phospholipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Role for phospholipase D in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Role of diacylglycerol kinase alpha in the attenuation of receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Diacylglycerol kinase zeta regulates Ras activation by a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Predisposition to neoplastic transformation caused by gene replacement of H-ras1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.5.643

21 January 2018

8

62

3893

MILLER WH Jr, SCHIPPER HM, LEE JS, SINGER J, WAXMAN S

publication date

2002

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

A novel protein kinase target for the lipid second messenger phosphatidic acid

11 March 2024

22

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Diacylglycerol kinases: emerging downstream regulators in cell signaling systems.

11 March 2024

26

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

A suppressor gene that enables Saccharomyces cerevisiae to grow without making sphingolipids encodes a protein that resembles an Escherichia coli fatty acyltransferase

11 March 2024

30

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells

11 March 2024

32

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross- contamination at source

11 March 2024

34

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction

11 March 2024

37

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate

11 March 2024

43

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

11 March 2024

44

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Expression of a catalytically inactive form of diacylglycerol kinase alpha induces sustained signaling through RasGRP.

11 March 2024

57

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

11 March 2024

63

1 reference

https://api.crossref.org/works/10.1517/14728222.7.5.643

11 March 2024

Identifiers

1 reference

8 August 2017

1 reference